Page last updated: 2024-08-16

terazosin and tamsulosin

terazosin has been researched along with tamsulosin in 91 studies

Research

Studies (91)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	25 (27.47)	18.2507
2000's	47 (51.65)	29.6817
2010's	17 (18.68)	24.3611
2020's	2 (2.20)	2.80

Authors

Authors	Studies
Ballard, S; Blagg, J; Fox, D; Kenny, B	1
Arredondo, NF; Bantle, GW; Blue, DR; Clarke, DE; DeSousa, A; Elworthy, TR; Ford, AP; Gross, LM; Kava, MS; Lesnick, JD; Morgans, DJ; Ozer, RS; Palmer, WS; Pfister, JR; Repke, DB; Romero, M; Sandoval, L; Sjogren, EB; Talamás, FX; Vazquez, A; Vimont, RL; Williams, TJ; Wu, H; Zhu, QM	1
Altenbach, RJ; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Drizin, I; Ehrlich, PP; Elmore, SW; Hancock, AA; Kerwin, JF; Lebold, SA; Meyer, MD; Plagge, F; Plata, DJ; Sippy, KB; Tietje, K; Wendt, MD	1
Altenbach, RJ; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Condon, S; Drizin, I; Elmore, SW; Hancock, AA; Kerwin, JF; Meyer, MD; Sippy, KB; Tietje, K; Wendt, MD	1
Barrish, A; Barrow, JC; Broten, TP; Chang, RS; Ellis, JD; Forray, C; Freidinger, RM; Gilbert, KF; Glass, KL; Homnick, CF; Kassahun, K; Kling, P; Leppert, P; Nagarathnam, D; Nantermet, PG; O'Malley, SS; Olah, TV; Ransom, RW; Reiss, D; Rittle, KE; Schorn, TW; Selnick, HG; Steele, TG	1
Altenbach, RJ; Bai, H; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Drizin, I; Hancock, AA; Kerwin, JF; Lebold, SA; Lee, E; Meyer, MD; Pratt, JK; Sippy, KB; Tietje, K; Wendt, MD	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bednarski, M; Canale, V; Knutelska, J; Kotańska, M; Marciniec, K; Nowiński, L; Rak, A; Sapa, J; Siwek, A; Stachowicz, G; Zajdel, P; Żmudzki, P; Zygmunt, M	1
Geller, J; Kirchenbaum, A; Lepor, H; Levine, AC	1
Breslin, D; Chou, TC; Felsen, D; Fields, DW; Kane, M; Marion, DN; Vaughan, ED	1
Carter, AJ; Greengrass, PM; Kenny, BA; Naylor, AM; Read, AM; Wyllie, MG	1
Drescher, P; Knes, JM; Madsen, PO; Rauch, D	1
Chapple, CR	2
Brune, ME; Buckner, SA; Hancock, AA; Ireland, LM; Katwala, SP; Kerwin, JF; Milicic, I	1
Andersson, KE; Lepor, H; Wyllie, MG	1
Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I	1
Chiba, T; Fukutomi, J; Hattori, K; Maruyama, K; Nagatomo, T; Takeda, M; Yamaguchi, M	1
Lee, C; Lee, E	1
Michel, MC; Schäfers, RF; Taguchi, K	1
Beduschi, MC; Beduschi, R; Oesterling, JE	1
de Mey, C; McEwen, J; Michel, MC; Moreland, T	1
Deguchi, Y; Higuchi, S; Honda, K; Inagaki, O; Kimura, R; Matsushima, H; Ohkura, T; Takenaka, T; Yamada, S	1
Muramatsu, I; Okada, K; Taniguchi, T	1
Bergman, JM; Broten, TP; Chang, RS; Chen, TB; Erb, JM; Guare, JP; Huff, JR; Lee, HY; Munson, PM; Nerenberg, JB; O'Malley, S; Schorn, TW; Scott, AL; Thompson, WJ	1
de Mey, C; Fokuhl, B; Michel, MC; Philipp, T; Schäfers, RF; Schumacher, H; Taguchi, K; Wasmuth, A	1
Fujimura, A; Harada, K; Kitoh, Y; Ohmori, M; Sugimoto, K	1
Gu, FL; Guo, YL; Na, YJ	1
Lee, TH	1
Alcini, E; Brisinda, G; Candidi, MO; Destito, A; Lacquaniti, S; Servello, C; Weir, JM	1
Hirao, Y; Kamidono, S; Kishimoto, T; Kurita, T; Okada, H; Okajima, E; Okuyama, A; Ozono, S; Park, Y; Yamamoto, K; Yoshioka, T	1
Tsujii, T	1
Clifford, GM; Farmer, RD	1
Benning, CM; Kyprianou, N	2
Benning, CM; Chon, J; Kyprianou, N	1
Caprino, L	1
de la ROSETTE, JJ; Floratos, DL; Kiemeney, LA; Kortmann, BB; Rossi, C; Sonke, GS; Wijkstra, H	1
Cotecchia, S; Goepel, M; Hein, P; Michel, MC	1
Fujioka, T; Goto, Y; Isurugi, K; Katoh, T; Numasato, S; Obara, W; Omori, S; Suzuki, Y	1
De la Rosette, JJ; Farmer, RD; Herings, RM; Leufkens, HG; Man in 't Veld, AJ; Souverein, PC	1
Agnello, G; Amadesi, S; Borea, PA; Daniele, C; Geppetti, P; Spisani, L; Turini, A; Varani, K; Zamboni, P	1
Brune, ME; Hancock, AA; Katwala, SP; Kerwin, JF; Meyer, MD; Milicic, I; Williams, M; Witte, DG	1
de la Rosette, JJ; Floratos, DL; Kiemeney, LA; Kortmann, BB; Rossi, C; Sonke, GS	1
Cecchi, M; Di Benedetto, A; Summonti, D	1
Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE	1
Keledjian, K; Kyprianou, N	1
Romics, I	1
Fukabori, Y; Honma, S; Kashiwagi, B; Ono, Y; Shibata, Y; Suzuki, K; Yamanaka, H	1
Barqawi, A; Crawford, ED; Gamito, E; O'Donnell, C	1
Doggrell, SA	1
Kyprianou, N; Rowland, RG; Tahmatzopoulos, A	1
Akbay, E; Bozlu, M; Cayan, S; Görür, S; Ulusoy, E	1
Basar, H; Basar, MM; Batislam, E; Ferhat, M; Tuglu, D; Yilmaz, E	1
Afshari, NA; Schwinn, DA	1
Nagano, M; Osada, Y; Yamaguchi, T	1
de la Rosette, JJ; Michel, MC	1
O'Leary, MP	1
Akova, YA; Altan-Yaycioglu, R; Ozkardes, H; Tufan, H; Yaycioglu, O	1
Kagawa, Y; Kato, Y; Kawabe, K; Okura, T; Yamada, S	1
Ku, JH; Song, YS	1
Jin, J; Kong, CZ; Li, NC; Na, YQ; Qiu, SP; Song, YS; Sun, G; Sun, YC; Sun, YH; Wang, XF; Wu, SL; Ye, ZQ	1
Kitteringham, NR; Macdonald, I; Park, BK; Randle, LE; Sathish, JG; Williams, DP	1
Chang, CH; Huang, SW; Wang, CJ	2
Rich, KT; Safranek, S	1
Mamalis, N	1
Cho, MC; Kim, SW; Ku, JH; Paick, JS; Song, SH	1
Bar-Yosef, Y; Kaver, I; Laufer, M; Mabjeesh, NJ; Matzkin, H; Neulander, EZ	1
Chatterjee, M; Gupta, D; Gupta, S; Nanda, K; Ray, A; Singh, R; Tiwar, A	1
Angelilli, A; De Moraes, CG; Liebmann, JM; Palmiero, PM; Prata, TS; Ritch, R; Sbeity, Z	1
Chen, W; Dong, Z; Gao, W; Liu, Y; Wang, Z; Yang, K	1
Combs, AJ; Glassberg, KI; Horowitz, M; Van Batavia, JP	1
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA	1
Chatziralli, IP; Sergentanis, TN	1
Alan, C; Eren, AE; Ersay, AR; Ertung, Y; Kırılmaz, B; Koçoğlu, H	1
Krome, S	1
Du, H; He, L; Ren, J; Wang, S	1
Casuccio, A; Cillino, G; Cillino, S; Pavone, C; Spitale, E	1
Hill, TM; McEwen, C; Sherman, JJ; Welch, RW	1
Araki, M; Araki, T; Monden, K	1
Barkin, J; Berner, T; Diles, D; Franks, B	1
Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P	1
Anoopkumar-Dukie, S; Chess-Williams, R; Forbes, A; McDermott, C	1
Daneshmand, S; Shamie, N; Zhang, Y	1
Hori, Y; Ohyama, K; Sugiura, M	1
Dahm, P; Hwang, EC; Koziarz, A; Kuntz, GM; Oestreich, MC; Sathianathen, NJ; Scales, CD; Vernooij, RW	1
Liu, L; Narayanan, NS; Pottegård, A; Simmering, JE; Welsh, MJ	1

Reviews

20 review(s) available for terazosin and tamsulosin

Article	Year
Pharmacological options in the treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship	1997
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Therapeutic controversies: clinical treatment of benign prostatic hyperplasia. The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:3 Topics: Adrenergic alpha-Antagonists; Cholestenone 5 alpha-Reductase; Clinical Trials as Topic; Drug Therapy, Combination; Finasteride; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Oxidoreductases; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1995
Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience. European urology, 1996, Volume: 29, Issue:2 Topics: Adrenergic alpha-Antagonists; Blood Pressure; Clinical Trials as Topic; Doxazosin; Half-Life; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Vasodilation	1996
Prostatic alpha 1-adrenoceptors and uroselectivity. The Prostate, 1997, Feb-15, Volume: 30, Issue:3 Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Humans; Male; Prazosin; Prostate; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1997
[Alpha blockers in the treatment of benign hyperplasia of the prostate]. Revista clinica espanola, 1997, Volume: 197, Issue:5 Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	1997
Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade. British journal of urology, 1998, Volume: 81 Suppl 1 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Hormones; Humans; Male; Patient Selection; Plant Extracts; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	1998
Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist. Urology, 1998, Volume: 51, Issue:6 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1998
Medical therapy for benign prostatic hyperplasia: a review of the literature. European urology, 2000, Volume: 38, Issue:1 Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2000
[Drugs for the treatment of benign prostatic hypertrophy]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2000, Volume: 52, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Androgen Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Muscle, Smooth; Plant Extracts; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Serenoa; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urodynamics	2000
[Pharmacologic treatment of benign prostatic hyperplasia]. Orvosi hetilap, 2003, Sep-14, Volume: 144, Issue:37 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2003
The role of alpha-blockers in the management of prostate cancer. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Angiogenesis Inhibitors; Anoikis; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Sulfonamides; Tamsulosin	2004
Treatment and pharmacologic management of BPH in the context of common comorbidities. The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome	2006
FPIN's clinical inquiries. Medical treatment of benign prostatic hyperplasia. American family physician, 2008, Mar-01, Volume: 77, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Antineoplastic Agents; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Practice Guidelines as Topic; Prazosin; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Treatment Outcome	2008
[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?]. Harefuah, 2008, Volume: 147, Issue:6 Topics: Adrenergic alpha-Antagonists; Doxazosin; Evidence-Based Medicine; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2008
Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review. Systems biology in reproductive medicine, 2009, Volume: 55, Issue:4 Topics: Adrenergic alpha-Antagonists; Humans; Male; Prazosin; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin	2009
Risk factors for intraoperative floppy iris syndrome: a meta-analysis. Ophthalmology, 2011, Volume: 118, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Diabetes Complications; Doxazosin; Humans; Hypertension; Incidence; Intraoperative Complications; Iris; Iris Diseases; Odds Ratio; Phacoemulsification; Prazosin; Quinazolines; Risk Factors; Sulfonamides; Syndrome; Tamsulosin	2011
[How effective is finasteride?]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:8 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Drug Therapy, Combination; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin	2011
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies. European urology, 2016, Volume: 69, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics	2016
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults. The Cochrane database of systematic reviews, 2020, 11-12, Volume: 11 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxazosin; Humans; Indoles; Kidney Calculi; Lithotripsy; Middle Aged; Prazosin; Quinazolines; Randomized Controlled Trials as Topic; Tamsulosin; Ureteral Calculi	2020

Trials

17 trial(s) available for terazosin and tamsulosin

Article	Year
Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses. British journal of urology, 1997, Volume: 80, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination	1997
Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics. British journal of clinical pharmacology, 1998, Volume: 45, Issue:1 Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Animals; Chromatography, High Pressure Liquid; Cloning, Molecular; Cross-Over Studies; Humans; Male; Placebos; Prazosin; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Single-Blind Method; Substrate Specificity; Sulfonamides; Tamsulosin; Transfection	1998
A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing. European urology, 1998, Volume: 33, Issue:5 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Double-Blind Method; Drug Administration Schedule; Heart Rate; Humans; Hypotension, Orthostatic; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Retention; Urodynamics; Vertigo	1998
Differential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosin. British journal of clinical pharmacology, 1999, Volume: 47, Issue:1 Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Drug Interactions; Hemodynamics; Humans; Male; Phenylephrine; Placebos; Prazosin; Single-Blind Method; Sulfonamides; Tamsulosin; Vasoconstriction	1999
A comparison of the antagonistic activities of tamsulosin and terazosin against human vascular alpha1-adrenoceptors. Japanese journal of pharmacology, 1999, Volume: 80, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Blood Vessels; Cross-Over Studies; Dose-Response Relationship, Drug; Fingers; Hand; Heart Rate; Humans; Male; Phenylephrine; Prazosin; Pulse; Regional Blood Flow; Sulfonamides; Tamsulosin; Vasoconstriction; Vasoconstrictor Agents; Veins	1999
Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group. Journal of medicine, 1998, Volume: 29, Issue:5-6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Dose-Response Relationship, Drug; Humans; Hypotension; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Single-Blind Method; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction	1998
Terazosine and tamsulosin in non bacterial prostatitis: a randomized placebo-controlled study. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 1999, Volume: 71, Issue:5 Topics: Adrenergic alpha-Antagonists; Adult; Humans; Male; Prazosin; Prospective Studies; Prostatitis; Sulfonamides; Tamsulosin	1999
A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients. BJU international, 2000, Volume: 85, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Drug Administration Schedule; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tamsulosin	2000
Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Study Group. Benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2000, Volume: 7, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urodynamics	2000
[The efficacy and safety of terazosin and tamsulosin in patients with urinary disturbance accompanying prostatic hypertrophy]. Hinyokika kiyo. Acta urologica Japonica, 2001, Volume: 47, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2001
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy. Urology, 2002, Volume: 60, Issue:4 Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Biopsy; Brachytherapy; Doxazosin; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Postoperative Complications; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination Disorders	2002
Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:5 Topics: Clinical Trials as Topic; Doxazosin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2004
The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. The Journal of urology, 2005, Volume: 173, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Doxazosin; Female; Humans; Male; Middle Aged; Pain Measurement; Prazosin; Sulfonamides; Tamsulosin; Treatment Outcome; Ureteral Calculi	2005
[Comparison of different drugs on the treatment of benign prostate hyperplasia]. Zhonghua wai ke za zhi [Chinese journal of surgery], 2007, Jul-15, Volume: 45, Issue:14 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androstadienes; Double-Blind Method; Doxazosin; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Plant Extracts; Prazosin; Prostate; Prostatic Hyperplasia; Quality of Life; Secale; Sulfonamides; Tamsulosin; Treatment Outcome	2007
Efficacy of an alpha1 blocker in expulsive therapy of lower ureteral stones. Journal of endourology, 2008, Volume: 22, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Female; Humans; Male; Middle Aged; Prazosin; Sulfonamides; Tamsulosin; Ureteral Calculi	2008
Adjunctive medical therapy with an alpha-1A-specific blocker after shock wave lithotripsy of lower ureteral stones. Urologia internationalis, 2009, Volume: 82, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Analgesics, Opioid; Buprenorphine; Colic; Combined Modality Therapy; Female; Humans; Lithotripsy; Male; Middle Aged; Pain; Pain Measurement; Pilot Projects; Prazosin; Prospective Studies; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Treatment Outcome; Ureteral Calculi	2009
Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study. Acta medica Okayama, 2013, Volume: 67, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Doxazosin; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2013

Other Studies

54 other study(ies) available for terazosin and tamsulosin

Article	Year
N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonists. Journal of medicinal chemistry, 1997, Aug-15, Volume: 40, Issue:17 Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Amides; Animals; Binding, Competitive; Humans; Male; Middle Aged; Models, Chemical; Muscle, Smooth; Piperazines; Prazosin; Propylamines; Prostatic Hyperplasia; Rabbits; Rats; Structure-Activity Relationship; Urinary Bladder	1997
Synthesis and pharmacological characterization of 3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e] isoindol-2-yl)ethyl]pyrido-[3',4':4,5]thieno[3,2-d]pyrimidine-2,4 (1H,3H)-dione (A-131701): a uroselective alpha 1A adrenoceptor antagonist Journal of medicinal chemistry, 1997, Sep-26, Volume: 40, Issue:20 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dogs; Humans; Indoles; Isoindoles; Male; Models, Chemical; Prazosin; Prostatic Hyperplasia; Pyrimidinones; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1997
Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH). Journal of medicinal chemistry, 2000, Apr-20, Volume: 43, Issue:8 Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cell Line; Dogs; Heterocyclic Compounds, 3-Ring; Indoles; Male; Pressure; Prostatic Hyperplasia; Radioligand Assay; Rats; Rats, Inbred SHR; Stereoisomerism; Structure-Activity Relationship; Urethra	2000
In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 2000, Jul-13, Volume: 43, Issue:14 Topics: Adrenergic alpha-Antagonists; Animals; Biological Availability; Caco-2 Cells; Crystallography, X-Ray; Dogs; Humans; Male; Prostatic Hyperplasia; Pyrimidinones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship	2000
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 2001, Jun-07, Volume: 44, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Dogs; Doxazosin; Drug Design; Humans; Indicators and Reagents; Indoles; Isoindoles; L Cells; Male; Mice; Models, Molecular; Molecular Conformation; Prazosin; Prostate; Prostatic Hyperplasia; Quinazolines; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Spleen; Structure-Activity Relationship; Vas Deferens	2001
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Arylsulfonamide derivatives of (aryloxy)ethyl pyrrolidines and piperidines as α Bioorganic & medicinal chemistry, 2016, 11-01, Volume: 24, Issue:21 Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Blood Pressure; Dose-Response Relationship, Drug; Humans; Injections, Intraperitoneal; Male; Molecular Structure; Piperidines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship; Sulfonamides	2016
Medical management of benign prostatic hyperplasia: a canine model comparing the in vivo efficacy of alpha-1 adrenergic antagonists in the prostate. The Journal of urology, 1993, Volume: 149, Issue:2 Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Epinephrine; Male; Muscle Contraction; Phenoxybenzamine; Prazosin; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Sulfonamides; Tamsulosin	1993
Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog. Urology, 1994, Volume: 44, Issue:1 Topics: Adrenergic alpha-Antagonists; Affinity Labels; Anesthesia, Endotracheal; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Male; Models, Biological; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin	1994
Contrast medium induced renal vasoconstriction, role of alpha receptors. Scandinavian journal of urology and nephrology. Supplementum, 1995, Volume: 172 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Contrast Media; Dose-Response Relationship, Drug; Drug Interactions; Phenylephrine; Piperazines; Prazosin; Rabbits; Radiography; Receptors, Adrenergic, alpha-1; Renal Artery; Sulfonamides; Tamsulosin; Vasoconstriction; Vasoconstrictor Agents	1995
Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs. Pharmacology, 1996, Volume: 53, Issue:6 Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dogs; Doxazosin; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Urethra	1996
Two district alpha(1)-adrenoceptor subtypes in the human prostate: assessment by radioligand binding assay using 3H-prazosin. General pharmacology, 1996, Volume: 27, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Binding, Competitive; Dioxanes; Humans; In Vitro Techniques; Kinetics; Male; Nifedipine; Phentolamine; Piperazines; Prazosin; Prostate; Protein Binding; Radioligand Assay; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tritium	1996
Ex vivo occupancy by tamsulosin of alpha1-adrenoceptors in rat tissues in relation to the plasma concentration. Life sciences, 1998, Volume: 63, Issue:24 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Animals; Male; Prazosin; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tissue Distribution	1998
Tamsulosin: alpha1-adrenoceptor subtype-selectivity and comparison with terazosin. Japanese journal of pharmacology, 1998, Volume: 78, Issue:3 Topics: Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Binding, Competitive; Dogs; Dose-Response Relationship, Drug; Humans; Male; Muscle Contraction; Norepinephrine; Prazosin; Prostate; Rabbits; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1998
Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists. Bioorganic & medicinal chemistry letters, 1998, Sep-22, Volume: 8, Issue:18 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Alkylation; Animals; Aorta; Cell Line; CHO Cells; Cricetinae; Dogs; Drug Design; Finasteride; Humans; In Vitro Techniques; Male; Models, Chemical; Prazosin; Prostate; Rats; Receptors, Adrenergic, alpha-1; Saccharin; Structure-Activity Relationship; Sulfonamides; Tamsulosin	1998
By the way, doctor... I'm 78 and have more and more difficulty urinating. I get up three times a night - sometimes more - to go to the bathroom and it takes me a while to start urinating and even longer to stop. I know that this is probably a prostate pro Harvard health letter, 1999, Volume: 24, Issue:12 Topics: Adrenergic alpha-Antagonists; Aged; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	1999
Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis. Cancer research, 2000, Aug-15, Volume: 60, Issue:16 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cells, Cultured; Doxazosin; Growth Inhibitors; Humans; Male; Mice; Mice, SCID; Muscle, Smooth; Neoplasm Transplantation; Prazosin; Prostate; Prostatic Neoplasms; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Tamsulosin; Transplantation, Heterologous	2000
Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease. The Prostate. Supplement, 2000, Volume: 9 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Biopsy; Cell Division; Doxazosin; Humans; Male; Muscle, Smooth; Prazosin; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Stromal Cells; Sulfonamides; Tamsulosin	2000
alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it. The Journal of urology, 2001, Volume: 165, Issue:1 Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Prazosin; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors; Urinary Bladder Neck Obstruction; Urodynamics	2001
A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors. Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 363, Issue:1 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Chromones; Cricetinae; Dose-Response Relationship, Drug; Doxazosin; Fibroblasts; Inositol Phosphates; Phenethylamines; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tetralones; Tritium	2001
Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations. Journal of clinical epidemiology, 2001, Volume: 54, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Adult; Aged; Bias; Cardiovascular Diseases; Case-Control Studies; Finasteride; Humans; Male; Middle Aged; Morbidity; Netherlands; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Research Design; Risk Factors; Sulfonamides; Tamsulosin	2001
Comparison of prazosin, terazosin and tamsulosin: functional and binding studies in isolated prostatic and vascular human tissues. The Prostate, 2001, Jun-01, Volume: 47, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Dose-Response Relationship, Drug; Female; Humans; Kinetics; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Prostate; Receptors, Adrenergic, alpha-1; Renal Artery; Saphenous Vein; Sulfonamides; Tamsulosin; Umbilical Veins	2001
Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Heterocyclic Compounds, 3-Ring; Male; Phenylephrine; Prazosin; Prostate; Pyrimidinones; Regional Blood Flow; Sulfonamides; Tamsulosin; Urethra	2002
Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action. Cancer research, 2002, Jan-15, Volume: 62, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tumor Cells, Cultured	2002
Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms. The Journal of urology, 2002, Volume: 167, Issue:4 Topics: Adrenergic beta-Antagonists; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Risk Factors; Sulfonamides; Tamsulosin; Time Factors; Treatment Failure	2002
[Comparison of prazosin, terazosin and tramsulosin: functional and binding studies in isolated prostatic and vascular human tissues]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2002, Volume: 54, Issue:3 Topics: Binding Sites; Blood Vessels; Humans; In Vitro Techniques; Male; Prazosin; Prostate; Sulfonamides; Tamsulosin	2002
Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2. The Journal of urology, 2003, Volume: 169, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anoikis; Cell Adhesion; Cell Survival; Doxazosin; Endothelial Growth Factors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Neoplasm Invasiveness; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tamsulosin; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2003
Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate. Urology, 2003, Volume: 62, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androgen Antagonists; Anilides; Animals; Capillaries; Chlormadinone Acetate; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hormone Antagonists; Male; Microcirculation; Nitriles; Prazosin; Prostate; Rats; Rats, Wistar; Sulfonamides; Tamsulosin; Testosterone; Tosyl Compounds	2003
Herbal and vitamin supplement use in a prostate cancer screening population. Urology, 2004, Volume: 63, Issue:2 Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Adult; Aged; Colorado; Complementary Therapies; Dietary Supplements; Doxazosin; Drug Utilization; Family; Finasteride; Health Surveys; Humans; Male; Mass Screening; Middle Aged; Penile Erection; Phytotherapy; Plant Preparations; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Self Medication; Socioeconomic Factors; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders; Vitamins	2004
A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes. Scandinavian journal of urology and nephrology, 2004, Volume: 38, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Probability; Prostatic Hyperplasia; Quinazolines; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics	2004
Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg? Ophthalmology, 2005, Volume: 112, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Phacoemulsification; Prazosin; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2005
Effects of different alpha-1 adrenoceptor blockers on proximal urethral function using in vivo isovolumetric pressure changes. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2005, Volume: 41, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiovascular System; Male; Phenylephrine; Prazosin; Quinazolines; Rabbits; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethra	2005
alpha-blocker treatment of urolithiasis. European urology, 2006, Volume: 50, Issue:2 Topics: Adrenergic alpha-Antagonists; Doxazosin; Drug Therapy, Combination; Glucocorticoids; Humans; Prazosin; Sulfonamides; Tamsulosin; Urolithiasis	2006
The effects of systemic alpha-1 adrenergic antagonists on pupil diameter in rats. Current eye research, 2007, Volume: 32, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Doxazosin; Iris; Male; Prazosin; Pupil; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin	2007
Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia. Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:7 Topics: Adrenergic alpha-Antagonists; Adult; Animals; Humans; Indoles; Male; Prazosin; Prostate; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	2007
Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study. International urology and nephrology, 2007, Volume: 39, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Prazosin; Prospective Studies; Prostatic Hyperplasia; Pyridines; Quality of Life; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics; Zolpidem	2007
alpha(1)-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice. British journal of pharmacology, 2008, Volume: 153, Issue:4 Topics: Acetaminophen; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Catecholamines; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Doxazosin; Erythrocytes; Gene Expression Regulation, Enzymologic; Glutamate-Cysteine Ligase; Glutathione; Heme Oxygenase-1; Liver; Liver Circulation; Liver Diseases; Male; Membrane Proteins; Mice; Prazosin; Protein Binding; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Time Factors; Transaminases	2008
Intraoperative floppy-iris syndrome associated with systemic alpha blockers. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2008
Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume. Journal of Korean medical science, 2008, Volume: 23, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Logistic Models; Male; Middle Aged; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Retrospective Studies; Sulfonamides; Tamsulosin; Treatment Outcome	2008
Functional screening of adrenergic receptors by measuring intracellular calcium using the FlexStation scanning fluorimeter. Biotechnology journal, 2009, Volume: 4, Issue:3 Topics: Animals; Biotechnology; Calcium; Cell Line; Dose-Response Relationship, Drug; Fluorescent Dyes; Fluorometry; GTP-Binding Proteins; Humans; Kinetics; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic; Signal Transduction; Sulfonamides; Tamsulosin	2009
Iris morphologic changes related to alpha(1)-adrenergic receptor antagonists implications for intraoperative floppy iris syndrome. Ophthalmology, 2009, Volume: 116, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Cross-Sectional Studies; Eye Color; Glaucoma; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Muscle, Smooth; Ocular Hypertension; Prazosin; Prospective Studies; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin; Tomography, Optical Coherence	2009
Primary bladder neck dysfunction in children and adolescents III: results of long-term alpha-blocker therapy. The Journal of urology, 2010, Volume: 183, Issue:2 Topics: Adolescent; Adrenergic alpha-Antagonists; Child; Child, Preschool; Female; Humans; Male; Prazosin; Sulfonamides; Tamsulosin; Time Factors; Urinary Bladder Neck Obstruction; Urination Disorders	2010
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors. The Journal of urology, 2010, Volume: 183, Issue:5 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin	2010
Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia. Urology, 2011, Volume: 77, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Blood Coagulation; Blood Pressure; Brachial Artery; Doxazosin; Endothelial Cells; Endothelium, Vascular; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography	2011
Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions. Analytical and bioanalytical chemistry, 2011, Volume: 400, Issue:10 Topics: Adrenergic alpha-1 Receptor Antagonists; Binding, Competitive; Cell Line; Cell Membrane; Chromatography; Doxazosin; Humans; Methods; Phentolamine; Piperazines; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	2011
Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome. Journal of cataract and refractive surgery, 2011, Volume: 37, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cohort Studies; Doxazosin; Drug Combinations; Humans; Intraoperative Complications; Iris Diseases; Male; Muscle, Smooth; Mydriatics; Phacoemulsification; Phenylephrine; Prazosin; Predictive Value of Tests; Prospective Studies; Pupil; Risk Factors; Sensitivity and Specificity; Sulfonamides; Syndrome; Tamsulosin; Tropicamide	2011
Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes. Journal of pharmacy practice, 2012, Volume: 25, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Family Practice; Humans; Indoles; Male; Middle Aged; Practice Patterns, Physicians'; Prazosin; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin	2012
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence. The Canadian journal of urology, 2015, Volume: 22, Issue:4 Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate	2015
Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines. The Prostate, 2016, Volume: 76, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Cell Survival; Doxazosin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides; Tamsulosin	2016
Assessment of Urologists' Knowledge of Intraoperative Floppy Iris Syndrome. Urology, 2016, Volume: 97 Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Competence; Fellowships and Scholarships; Female; Finasteride; Health Knowledge, Attitudes, Practice; Humans; Internship and Residency; Intraoperative Complications; Iris Diseases; Male; Medical Staff, Hospital; Ophthalmology; Patient Education as Topic; Prazosin; Prostatic Hyperplasia; Referral and Consultation; Sulfonamides; Surveys and Questionnaires; Syndrome; Tamsulosin; Urological Agents; Urology; Vision Disorders	2016
Evaluation of syncope association with α Die Pharmazie, 2019, 12-01, Volume: 74, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Doxazosin; Humans; Hypertension; Indoles; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Syncope; Tamsulosin	2019
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease. JAMA neurology, 2021, 04-01, Volume: 78, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Denmark; Doxazosin; Female; Follow-Up Studies; Glycolysis; Humans; Male; Middle Aged; Parkinson Disease; Prazosin; Quinazolines; Registries; Risk Factors; Tamsulosin; United States	2021